| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000030448 |
| Receipt No. | R000034765 |
| Official scientific title of the study | Low-power extracorporeal shock wave therapy for improvement of blood pressure and suppression of renal function reduction in CKD patients diagnosed as chronic kidney disease (CKD) stage 3, 4 |
| Date of disclosure of the study information | 2019/04/01 |
| Last modified on | 2017/12/18 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Low-power extracorporeal shock wave therapy for improvement of blood pressure and suppression of renal function reduction in CKD patients diagnosed as chronic kidney disease (CKD) stage 3, 4 | |
| Title of the study (Brief title) | ESWT-CKD | |
| Region |
|
|
| Condition | ||
| Condition | CKD stage 3 &4 patients | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | By using an extracorporeal shock wave device, we evaluate the effectiveness of low power extracorporeal shock wave therapy for improving blood pressure, an important risk factor of CKD progression, in CKD stage 3 &4 patients. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | improvement of mean blood pressure |
| Key secondary outcomes | improvement of eGFR |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Extracorporeal Shock Wave | |
| Interventions/Control_2 | control | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | CKD stage 3 & 4 patients with at least one history of hypertension, diabetes, dyslipidemia, smoking history, cardiovascular complications | |||
| Key exclusion criteria | Patients with a local skin infection at the contact site with the applicator
Patients with bleeding tendency Patients with urolithiasis or kidney stones Patients with hydronephrosis Patients with active pyelonephritis Patients with cancer Patients treated with steroids or immunosuppressants Patients who is expected to introduce dialysis within 12 weeks Polycystic kidney disease patients Patients with renal morphological abnormality Patients who received kidney transplantation Dialysis patients (HD, PD) Patients whose renal blood flow cannot be evaluated Objects considered by the attending physician as inappropriate |
|||
| Target sample size | 66 | |||
| Research contact person | |
| Name of lead principal investigator | Yoshitaka Isaka |
| Organization | Osaka University Graduate School of Medicine |
| Division name | Nephrology |
| Address | 2-2, Yamadaoka, Suita |
| TEL | 0668793857 |
| isaka@kid.med.osaka-u.ac.jp | |
| Public contact | |
| Name of contact person | Yoshitaka Isaka |
| Organization | Osaka University Graduate School of Medicine |
| Division name | Nephrology |
| Address | 2-2, Yamadaoka, Suita |
| TEL | 0668793857 |
| Homepage URL | |
| isaka@kid.med.osaka-u.ac.jp | |
| Sponsor | |
| Institute | Osaka University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Osaka University Graduate School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034765 |